Anebulo Pharmaceuticals Inc. Made Headway
Mon, Dec 05, 2022 at 07:03 PM
Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ) shot up at $3.39, representing a gain of 27.9%. On Mon, Dec 05, 2022, ANEB:NASDAQ touched a New 2-Week High of $3.39. The stock got featured on our News Catalysts scanner on Thu, Nov 10, 2022 at 11:24 AM in the 'EARNINGS' category. From Mon, Nov 21, 2022, the stock recorded 50.00% Up Days and 66.67% Green Days
About Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ)
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction.
Top 10 Gainers:
- Winc Inc. (WBEV:NYSEMKT), 100.1%
- Mmtec, Inc. (MTC:NASDAQ), 50%
- Nymox Pharmaceutical Corporation (NYMX:NASDAQ), 44.81%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 44.38%
- Digital Brands Group Inc. (DBGI:NASDAQ), 37.33%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 34.88%
- EHang Holdings Limited (EH:NASDAQ), 34.27%
- Vivani Medical Inc. Com (VANI:NASDAQ), 31.18%
- Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 27.92%
- Titan Medical Inc. (TMDI:NASDAQ), 27.82%